SecBot SecBot
DEFA14A ·Filed Nov 10, 2026

HSCS

HeartSciences Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed7d ago SEC0001213900-26-118108
Proxy solicitation materials
Actionable Insight • Neutral

Monitor the special meeting vote outcome and any additional proxy solicitation materials. The merger transforms HeartSciences from an AI medical device company into a crypto mining entity, creating a binary event for shareholders.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$2.30
T+0 close · Nov 10, 2026 · via day close
Latest settled
−1.53%
T+1 · $2.26
Vs SPY
−1.17%
α at T+1
Next horizon
T+5
in 13h
  1. T+0 · Nov 11 $2.30entry
  2. T+1 · 5d ago −1.53%α −1.17% · $2.26
  3. T+4 · todayOpen
  4. T+5 · in 13h Pending
  5. T+20 · in 23d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

HeartSciences filed additional definitive proxy soliciting materials (DEFA14A) in connection with its proposed all-stock merger with Fortitude Mining Holdings, Inc. The filing includes social media posts from Digital Currency Group (DCG) and a DCG executive, supporting the transaction. The special meeting to vote on the merger is pending, with the definitive proxy statement filed on October 19, 2026.

Key Financial Metrics

Vote
merger approval

Key Facts

  • HeartSciences and Fortitude Mining Holdings have entered into a definitive merger agreement for an all-stock transaction.
  • The definitive proxy statement was filed on October 19, 2026, and mailed to shareholders.
  • This DEFA14A includes social media posts from DCG and a DCG executive in support of the merger.
  • Fortitude is a vertically-integrated digital asset mining platform anchored in Zcash, backed by DCG.
  • The merger requires HeartSciences shareholder approval at a special meeting.
  • CEO Andrew Simpson's SC 13D/A (filed Oct 24, 2026) disclosed unchanged 7.5% beneficial ownership following FDA 510(k) clearance of MyoVista wavECG device.

Financial Impact

All-stock transaction; no deal value disclosed in this filing.

Risk Factors

  • Risk that the merger may not be completed on the anticipated timeline or at all.
  • Failure to obtain requisite HeartSciences shareholder approval.
  • Highly volatile nature of Zcash and other cryptocurrency prices affecting Fortitude's business.
  • Significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally.

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001213900-26-118108
Document: 0001213900-26-118108-index-headers.html0001213900-26-118108
Document: 0001213900-26-118108-index.html0001213900-26-118108
Document: 0001213900-26-118108.txt0001213900-26-118108

Track record

73 reports on HSCS

Performance horizon

6 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +92.83% at T+20 after the Aug 20, 2026 report. 7 of 7 went positive at some point.

Filters
  1. Nov 17, 2026today S-3/A Bearish 5/10 Entry $2.13 Now $2.06 +3.29% settles Nov 19
  2. Nov 17, 2026today DEFA14A Neutral 5/10 Entry $2.13 Now $2.06 −3.29% settles Nov 18
  3. Nov 13, 20264d ago DEFA14A Neutral 5/10 Entry $2.08 to $2.06 Now $2.06 −0.96% ▼ −0.96% +0.05% vs SPY
  4. Nov 13, 20264d ago DEFA14A Neutral 4/10 Entry $2.13 to $2.08 Now $2.06 −3.06% ▼ −2.12% −0.21% vs SPY
  5. Nov 13, 20264d ago 8-K/A Bearish 5/10 Entry $2.13 to $2.08 Now $2.06 +3.06% ▲ +2.12% +0.21% vs SPY
  6. Nov 12, 20265d ago DEFA14A Neutral 4/10 Entry $2.26 to $2.13 Now $2.06 −8.85% ▼ −5.97% −5.61% vs SPY
  7. Nov 10, 20267d ago DEFA14A Neutral 4/10 Viewing Entry $2.30 to $2.26 Now $2.06 −10.24% ▼ −1.53% −1.17% vs SPY
  8. Nov 10, 20267d ago DEFA14A Neutral 4/10 Entry $2.40 to $2.30 Now $2.06 −13.99% ▼ −4.18% −5.49% vs SPY
  9. Nov 10, 20267d ago DEFA14A Neutral 3/10 Entry $2.40 to $2.30 Now $2.06 −13.99% ▼ −4.18% −5.49% vs SPY
  10. Nov 9, 20268d ago DEFA14A Neutral 4/10 Entry $2.40 to $2.30 Now $2.06 −13.99% ▼ −4.18% −5.49% vs SPY
Showing 10 of 73

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026